Linical Co

Linical Co FCF/Net Income

The Free Cash Flow to Net Income Ratio of Linical Co (2183.T) as of Nov 3, 2026 is 46.66 %. In the previous year, Free Cash Flow to Net Income Ratio was -111.71 % — a change of -141.77% (higher).

FCF/Net Income

46.66 %

YoY

-141.77%

Last updated:

Free Cash Flow to Net Income Ratio of Linical Co is 2026 46.66 % . Free Cash Flow to Net Income Ratio of Linical Co was 2025 -111.71 % . It decreases by -141.77% higher compared to the previous year.

The Linical Co FCF/Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Net Income
Date
FCF/Net Income
Jan 1, 2019
-146.74 JPY
Jan 1, 2020
219.58 JPY
Jan 1, 2021
-8.31 JPY
Jan 1, 2022
200.55 JPY
Jan 1, 2023
181.85 JPY
Jan 1, 2024
318.60 JPY
Jan 1, 2025
-111.71 JPY
Jan 1, 2026
46.66 JPY
The Linical Co FCF/Net Income history
YEARFCF/Net IncomeYoY
46.66 %-141.77%
-111.71 %-135.06%
318.60 %+75.21%
181.85 %-9.33%
200.55 %-2,512.30%
-8.31 %-103.79%
219.58 %-249.64%
-146.74 %-246.40%
100.24 %-35.90%
156.37 %+17.01%
133.64 %-13.60%
154.67 %+192.25%
52.93 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Linical Co Stock analysis

What does Linical Co do? Linical Co., Ltd. generates revenue through two distinct business segments, the CRO segment and the Pharmaceutical Sales Support segment. The CRO segment provides contract monitoring, quality management, and consulting services specifically for phase II and phase III in drug development processes. These services are delivered to pharmaceutical companies as part of pharmaceutical contract research projects. The Pharmaceutical Sales Support segment focuses on the downstream market by providing pharmaceutical sales support for medical institutions. The company operates these businesses from its headquarters in Osaka, Osaka-Fu, leveraging its workforce of 759 full-time employees to deliver these specialized services. Linical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linical Co stock

Free Cash Flow to Net Income Ratio of Linical Co is 46.66 % in 2026.

Free Cash Flow to Net Income Ratio of Linical Co changed from -111.71 % to 46.66 %, representing a -141.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Net Income Ratio Linical Co since 2006 – with annual values, charts, and detailed analysis.

The FCF/Net Income ratio measures cash flow quality. Ratios consistently above 100% suggest high-quality earnings with strong cash backing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Net Income Ratio's Linical Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow to Net Income Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow to Net Income Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Linical Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Linical Co